nsclc

Value of Bai combined with BAE for the treatment of advanced NSCLC

支气管动脉灌注加栓塞治疗非小细胞肺癌的价值

Circulating endothelial cells in the peripheral blood of advanced NSCLC patients

晚期非小细胞肺癌循环血管内皮细胞水平的研究

Peripheral Blood Cell Analyze and Their Relationship with Prognosis of Advanced NSCLC Patients

外周血细胞分析与NSCLC晚期患者预后的相关性

Conclusion 3DCRT can improve local control rate and survival quality for NSCLC .

结论3DCRT可有效提高NSCLC患者肿瘤局部控制率和生存质量。

Clinical Analysis on Coagulation Markers in Advanced NSCLC Patients

晚期非小细胞肺癌患者凝血指标的临床分析

Clinical Analysis on 254 cases Female NSCLC

女性非小细胞肺癌254例临床分析

Clinical study of BCG-PSN combined with operation or chemotherapy in treating NSCLC

BCG-PSN与手术或化疗联合治疗非小细胞肺癌的临床探讨

Mutant p53 gene could be related with differentiation degree of NSCLC .

突变型P53在不同分化程度NSCLC中的表达差异提示突变型p53基因可能与NSCLC的恶性程度有关。

Gemcitabine Combination Therapy in 36 Cases Senile Terminal NSCLC Clinical Observation

吉西他滨联合长春瑞滨治疗36例老年晚期非小细胞肺癌临床观察

Conclusion Integrated Chinese and western medical treatment for advanced NSCLC has better cost-effect ratio .

结论中西医结合治疗晚期NSCLC有较好的成本效果比。

NSCLC accounts for about 80 % of the total number of lung cancer patients .

NSCLC约占肺癌病人总数的80%，其中以肺鳞状细胞癌和肺腺癌为主。

Research on Molecular Mechanism of Non-small Cell Lung Cancer ( NSCLC ) Based on Bioinformatics

非小细胞肺癌发生分子机制的生物信息学研究

Application Study of Gemcitabine and Cisplatin in Interventional Therapy on Advanced NSCLC

动脉介入健择、顺铂治疗肺癌的临床研究

Conclusions The double pathway was effective and safe in the treatment of advanced NSCLC patients .

结论上述双途径治疗法可作为晚期非小细胞肺癌安全有效的治疗方法。

Methods Analysis of 33 cases of NSCLC treated by Taxol and Carboplatin .

方法对33例应用泰素加卡铂治疗的晚期非小细胞肺癌患者进行分析。

The Response Rate of High Dose Epirubicin in Comparison with Conventional Dose on NSCLC

高剂量与常规剂量表阿霉素治疗NSCLC疗效比较

This information warrants further investigation of subpopulations in treatment of advanced NSCLC .

这些信息使进一步调查晚期非小细胞肺癌治疗亚组成为有理由的。

Cost-effective analysis of PET application in NSCLC

NSCLC患者行PET检查的成本效益分析

Study on the Expression of BI-1 and Relative Regulators in Human NSCLC Cell Lines

BI-1蛋白及其相关调控因子在非小细胞肺癌细胞系中的表达研究

Effects of Two Different TNF-related Apoptosis Inducing Ligands on NSCLC

两种不同形式的TNF相关凋亡诱导配体对非小细胞肺癌作用的研究

The clinical value of measuring glycosaminoglycan sulfate segments to the diagnosis of NSCLC

硫酸粘多糖片段检测对非小细胞肺癌诊断价值的探讨

NSCLC patients at different stages of disease may be treated with vaccines of different CT antigen composition .

对不同NSCLC肿瘤分期的病人可采取不同CT抗原成分疫苗；

Objective To study the clinicopathological significance of heparanase and VEGF expression in NSCLC .

目的探讨肝素酶基因及血管内皮生长因子（VEGF）在非小细胞肺癌（NSCLC）中的表达及其临床病理学意义。

The combination of the two indexes may be a useful prognostic indicator for patients with NSCLC .

两指标联合应用可作为预测NSCLC预后的比较客观的指标。

Methods 113 NSCLC patients were examined with whole body bone imaging using 99mTc-MDP as developer .

方法对113例NSCLC患者应用99mTc-亚甲基二膦酸盐（99mTc-MDP）进行全身骨显像。

Methods : Patients studied were non operable NSCLC and recurrent or metastatic breast cancer .

方法：转移或复发的晚期乳腺癌以及不能手术的Ⅲ&Ⅳ期非小细胞肺癌的病人。

Diagnosis and reversion of chemotherapy resistance in MDR - 1 NSCLC

非小细胞肺癌MDR-1型化疗耐药的诊断及逆转的研究

Methods Twenty four patients with NSCLC were evaluated with 18 FDG PET examination before operation .

方法术前对24例NSCLC患者进行18FDGPET检查。

Real-time PCR and Immunohistochemistry Detecting the Expression of Survivin in NSCLC and the Clinical Significance

实时荧光定量PCR及免疫组化检测非小细胞肺癌中Survivin表达及意义

Methods The clinical data of18 patients with NSCLC and solitary brain metastasis were retrospectively analysed .

方法回顾性分析18例NSCLC单发脑转移患者的临床资料。